Ingersoll Rand Reports First Quarter 2026 Results
Solid First Quarter Performance; on track to achieve full-year commitments
First Quarter 2026 Highlights
(All comparisons against the first quarter of 2025 unless otherwise noted).
Performance driven by its competitive differentiator -
-
Reported orders of
$1,978 million , up 5% -
Reported revenues of
$1,847 million , up 8% -
Reported net income attributable to
Ingersoll Rand Inc. of$192 million ,$0.49 per share-
Adjusted net income attributable to
Ingersoll Rand Inc. 1 of$305 million ,$0.77 per share, up 7%
-
Adjusted net income attributable to
-
Adjusted EBITDA1 of
$469 million , up 2%, with a margin of 25.4% -
Reported operating cash flow of
$200 million and free cash flow1 of$163 million -
Liquidity of
$3.9 billion as ofMarch 31, 2026 , including$1.3 billion of cash on hand and undrawn capacity of$2.6 billion under available credit facilities
“We began 2026 with solid momentum, delivering high single-digit Adjusted EPS1 growth and meeting our expectations for revenue and Adjusted EBITDA1,” said
First Quarter 2026 Segment Review
(All comparisons against the first quarter of 2025 unless otherwise noted.)
-
Reported Orders
of
$1,558 million , up 5%, or down 3% organic -
Reported Revenues
of
$1,445 million , up 7%, or down 2% organic1 -
Reported Segment Adjusted EBITDA
of
$386 million , down 1% - Reported Segment Adjusted EBITDA Margin of 26.7%, down 210 basis points
-
IT&S orders, excluding the impact from the
Middle East , finished approximately flat on an organic basis. The Company expects theseMiddle East orders to be recovered throughout the balance of the year. Revenue finished in line with expectations resulting in a book to bill of 1.08x. Adjusted EBITDA margin was down year over year, driven largely by the flow-through on organic volume declines, tariff pricing which offset tariff costs one-for-one, and continued commercial investments for growth.
Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air, and powder handling technologies for life sciences and industrial applications as well as aerospace and defense applications
-
Reported Orders
of
$420 million , up 6%, or up 1% organic -
Reported Revenues
of
$403 million , up 10%, or up 4% organic1 -
Reported Segment Adjusted EBITDA
of
$122 million , up 15% - Reported Segment Adjusted EBITDA Margin of 30.3%, up 120 basis points
- In the first quarter, P&ST saw continued momentum in organic order and revenue growth resulting in a book to bill of 1.04x. Adjusted EBITDA margin finished at 30.3% which was up 120 basis points year over year driven by strong operational execution fueled by IRX.
| ____________________ | |
| 1 Non-GAAP measure (definitions and/or reconciliations in tables below) |
Balance Sheet and Cash Flow
In the first quarter of 2026,
In
2026 Guidance3,4,5,6
|
Guidance Metric |
Full Year 2026 |
Full Year Assumptions* |
|
Revenue Growth3 |
2.5% to 4.5% |
|
|
Adjusted EBITDA4 |
|
|
|
Adjusted EPS4 |
+5% growth at the midpoint |
|
|
Free Cash Flow4 to Adj. Net Income conversion |
~95% |
|
- The phasing of Revenue, Adjusted EBITDA, and Adjusted EPS is consistent with prior years.
-
The Company does not expect any significant impact on its full-year guidance relating to:
- The recent changes in Section 232 tariffs.
-
The current conflict in the
Middle East .
Reconciliations of non-GAAP measures related to full-year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
| ____________________ |
|
2 Calculated as Net Debt to LTM Adjusted EBITDA |
|
3 All revenue outlook commentary expressed in percentages and based on growth as compared to 2025 |
|
4 Non-GAAP measure (definitions and/or reconciliations in tables below) |
|
5 Based on |
|
6 Reflects all completed, closed, and signed M&A as of |
Conference Call
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the expectations of
These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to geopolitical tensions, natural disaster, catastrophe, global pandemics, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the
Any forward-looking statements speak only as of the date of this release.
About
Non-
In addition to consolidated GAAP financial measures,
Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition,
Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to
Reconciliations of Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to
Reconciliations of non-GAAP measures related to full-year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
Due to rounding, numbers presented throughout this release may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; in millions, except per share amounts) |
|||||||
|
|
For the Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Revenues |
$ |
1,847.2 |
|
|
$ |
1,716.8 |
|
|
Cost of sales |
|
1,054.8 |
|
|
|
951.3 |
|
|
Gross Profit |
|
792.4 |
|
|
|
765.5 |
|
|
Selling and administrative expenses |
|
370.7 |
|
|
|
350.0 |
|
|
Amortization of intangible assets |
|
107.5 |
|
|
|
91.3 |
|
|
Other operating expense, net |
|
24.5 |
|
|
|
21.7 |
|
|
Operating Income |
|
289.7 |
|
|
|
302.5 |
|
|
Interest expense |
|
63.8 |
|
|
|
61.2 |
|
|
Other income, net |
|
(4.0 |
) |
|
|
(11.8 |
) |
|
Income Before Income Taxes |
|
229.9 |
|
|
|
253.1 |
|
|
Provision for income taxes |
|
36.1 |
|
|
|
58.5 |
|
|
Loss on equity method investments |
|
— |
|
|
|
(6.2 |
) |
|
Net Income |
|
193.8 |
|
|
|
188.4 |
|
|
Less: Net income attributable to noncontrolling interests |
|
1.7 |
|
|
|
1.9 |
|
|
Net Income Attributable to |
$ |
192.1 |
|
|
$ |
186.5 |
|
|
|
|
|
|
||||
|
Basic earnings per share |
|
0.49 |
|
|
|
0.46 |
|
|
Diluted earnings per share |
|
0.49 |
|
|
|
0.46 |
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited; in millions, except share amounts) |
|||||||
|
|
|
|
|
||||
|
Assets |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
1,274.4 |
|
|
$ |
1,248.8 |
|
|
Accounts receivable, net of allowance for credit losses of |
|
1,455.2 |
|
|
|
1,518.0 |
|
|
Inventories |
|
1,236.2 |
|
|
|
1,172.9 |
|
|
Other current assets |
|
324.0 |
|
|
|
308.3 |
|
|
Total current assets |
|
4,289.8 |
|
|
|
4,248.0 |
|
|
Property, plant and equipment, net of accumulated depreciation of |
|
920.0 |
|
|
|
930.3 |
|
|
|
|
8,471.2 |
|
|
|
8,484.1 |
|
|
Other intangible assets, net |
|
4,142.8 |
|
|
|
4,240.3 |
|
|
Deferred tax assets |
|
43.2 |
|
|
|
38.7 |
|
|
Other assets |
|
351.2 |
|
|
|
355.8 |
|
|
Total assets |
$ |
18,218.2 |
|
|
$ |
18,297.2 |
|
|
Liabilities and Stockholders' Equity |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Short-term borrowings and current maturities of long-term debt |
$ |
1.4 |
|
|
$ |
1.4 |
|
|
Accounts payable |
|
847.4 |
|
|
|
996.1 |
|
|
Accrued liabilities |
|
1,077.4 |
|
|
|
1,068.8 |
|
|
Total current liabilities |
|
1,926.2 |
|
|
|
2,066.3 |
|
|
Long-term debt, less current maturities |
|
4,777.4 |
|
|
|
4,783.3 |
|
|
Pensions and other postretirement benefits |
|
130.2 |
|
|
|
134.2 |
|
|
Deferred income tax liabilities |
|
716.7 |
|
|
|
696.9 |
|
|
Other liabilities |
|
427.9 |
|
|
|
462.5 |
|
|
Total liabilities |
$ |
7,978.4 |
|
|
$ |
8,143.2 |
|
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock, |
|
4.3 |
|
|
|
4.3 |
|
|
Capital in excess of par value |
|
9,729.4 |
|
|
|
9,699.9 |
|
|
Retained earnings |
|
3,237.4 |
|
|
|
3,053.1 |
|
|
Accumulated other comprehensive loss |
|
(189.7 |
) |
|
|
(148.3 |
) |
|
|
|
(2,606.3 |
) |
|
|
(2,519.2 |
) |
|
Total |
$ |
10,175.1 |
|
|
$ |
10,089.8 |
|
|
Noncontrolling interests |
|
64.7 |
|
|
|
64.2 |
|
|
Total stockholders’ equity |
$ |
10,239.8 |
|
|
$ |
10,154.0 |
|
|
Total liabilities and stockholders’ equity |
$ |
18,218.2 |
|
|
$ |
18,297.2 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited; in millions) |
|||||||
|
|
Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Cash Flows From Operating Activities: |
|
|
|||||
|
Net income |
$ |
193.8 |
|
|
$ |
188.4 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
|
Amortization of intangible assets |
|
107.5 |
|
|
|
91.3 |
|
|
Depreciation |
|
29.4 |
|
|
|
28.7 |
|
|
Stock-based compensation expense |
|
15.9 |
|
|
|
14.2 |
|
|
Loss on equity method investments |
|
— |
|
|
|
6.2 |
|
|
Foreign currency transaction losses, net |
|
2.2 |
|
|
|
6.8 |
|
|
Non-cash adjustments to carrying value of LIFO inventories |
|
5.4 |
|
|
|
3.0 |
|
|
Other non-cash adjustments |
|
1.0 |
|
|
|
2.4 |
|
|
Changes in assets and liabilities: |
|
|
|
||||
|
Receivables |
|
59.7 |
|
|
|
25.3 |
|
|
Inventories |
|
(74.7 |
) |
|
|
(54.1 |
) |
|
Accounts payable |
|
(133.5 |
) |
|
|
(70.4 |
) |
|
Accrued liabilities |
|
16.0 |
|
|
|
39.7 |
|
|
Other assets and liabilities, net |
|
(23.0 |
) |
|
|
(25.1 |
) |
|
Net cash provided by operating activities |
|
199.7 |
|
|
|
256.4 |
|
|
Cash Flows Used In Investing Activities: |
|
|
|
||||
|
Capital expenditures |
|
(36.3 |
) |
|
|
(33.7 |
) |
|
Net cash paid in acquisitions |
|
(52.0 |
) |
|
|
(163.4 |
) |
|
Proceeds from disposals of property, plant and equipment |
|
3.9 |
|
|
|
— |
|
|
Net cash used in investing activities |
|
(84.4 |
) |
|
|
(197.1 |
) |
|
Cash Flows Used In Financing Activities: |
|
|
|
||||
|
Purchases of treasury stock |
|
(89.5 |
) |
|
|
(10.0 |
) |
|
Cash dividends on common shares |
|
(7.8 |
) |
|
|
(8.1 |
) |
|
Proceeds from stock option exercises |
|
15.9 |
|
|
|
5.2 |
|
|
Payments of deferred and contingent acquisition consideration |
|
(1.4 |
) |
|
|
(1.4 |
) |
|
Other financing |
|
(1.0 |
) |
|
|
4.3 |
|
|
Net cash used in financing activities |
|
(83.8 |
) |
|
|
(10.0 |
) |
|
Effect of exchange rate changes on cash and cash equivalents |
|
(5.9 |
) |
|
|
22.3 |
|
|
Net increase in cash and cash equivalents |
|
25.6 |
|
|
|
71.6 |
|
|
Cash and cash equivalents, beginning of period |
|
1,248.8 |
|
|
|
1,541.2 |
|
|
Cash and cash equivalents, end of period |
$ |
1,274.4 |
|
|
$ |
1,612.8 |
|
|
UNAUDITED ADJUSTED FINANCIAL INFORMATION (Dollars in millions) |
|||||||
|
|
For the Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Revenues |
$ |
1,847.2 |
|
|
$ |
1,716.8 |
|
|
Adjusted EBITDA |
$ |
469.1 |
|
|
$ |
459.7 |
|
|
Adjusted EBITDA Margin |
|
25.4 |
% |
|
|
26.8 |
% |
|
Free Cash Flow |
$ |
163.4 |
|
|
$ |
222.7 |
|
|
Free Cash Flow Margin |
|
8.8 |
% |
|
|
13.0 |
% |
|
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND ADJUSTED NET INCOME ATTRIBUTABLE TO INGERSOLL RAND INC. AND ADJUSTED DILUTED EARNINGS PER SHARE (Unaudited; in millions) |
|||||||
|
|
For the Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Net Income |
$ |
193.8 |
|
|
$ |
188.4 |
|
|
Plus: |
|
|
|
||||
|
Provision for income taxes |
|
36.1 |
|
|
|
58.5 |
|
|
Amortization of acquisition related intangible assets |
|
105.2 |
|
|
|
89.0 |
|
|
Restructuring and related business transformation costs |
|
8.7 |
|
|
|
5.4 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
13.6 |
|
|
|
9.8 |
|
|
Stock-based compensation |
|
15.9 |
|
|
|
14.2 |
|
|
Foreign currency transaction losses, net |
|
2.2 |
|
|
|
6.8 |
|
|
Loss on equity method investments |
|
— |
|
|
|
6.2 |
|
|
Adjustments to LIFO inventories |
|
5.4 |
|
|
|
3.0 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
(0.2 |
) |
|
Other adjustments |
|
(1.1 |
) |
|
|
(2.2 |
) |
|
Minus: |
|
|
|
||||
|
Income tax provision, as adjusted |
|
75.2 |
|
|
|
85.7 |
|
|
Adjusted Net Income |
|
304.6 |
|
|
|
293.2 |
|
|
Less: Net income attributable to noncontrolling interest |
|
1.7 |
|
|
|
1.9 |
|
|
Adjusted Net Income Attributable to |
$ |
302.9 |
|
|
$ |
291.3 |
|
|
|
|
|
|
||||
|
Adjusted Basic Earnings Per Share1 |
$ |
0.77 |
|
|
$ |
0.72 |
|
|
Adjusted Diluted Earnings Per Share2 |
$ |
0.77 |
|
|
$ |
0.72 |
|
|
|
|
|
|
||||
|
Average shares outstanding: |
|
|
|
||||
|
Basic, as reported |
|
391.4 |
|
|
|
403.1 |
|
|
Diluted, as reported |
|
394.0 |
|
|
|
406.4 |
|
|
Adjusted diluted2 |
|
394.0 |
|
|
|
406.4 |
|
|
1 Basic and diluted earnings per share (as reported) are calculated by dividing net income attributable to |
|||||||
| 2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding. | |||||||
|
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW (Unaudited; in millions) |
|||||||
|
|
For the Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Net Income |
$ |
193.8 |
|
|
$ |
188.4 |
|
|
Plus: |
|
|
|
||||
|
Interest expense |
|
63.8 |
|
|
|
61.2 |
|
|
Provision for income taxes |
|
36.1 |
|
|
|
58.5 |
|
|
Depreciation expense |
|
28.3 |
|
|
|
27.6 |
|
|
Amortization expense |
|
107.5 |
|
|
|
91.3 |
|
|
Restructuring and related business transformation costs |
|
8.7 |
|
|
|
5.4 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
13.6 |
|
|
|
9.8 |
|
|
Stock-based compensation |
|
15.9 |
|
|
|
14.2 |
|
|
Foreign currency transaction losses, net |
|
2.2 |
|
|
|
6.8 |
|
|
Loss on equity method investments |
|
— |
|
|
|
6.2 |
|
|
Adjustments to LIFO inventories |
|
5.4 |
|
|
|
3.0 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
(0.2 |
) |
|
Interest income on cash and cash equivalents |
|
(5.1 |
) |
|
|
(10.3 |
) |
|
Other adjustments |
|
(1.1 |
) |
|
|
(2.2 |
) |
|
Adjusted EBITDA |
$ |
469.1 |
|
|
$ |
459.7 |
|
|
Minus: |
|
|
|
||||
|
Interest expense |
|
63.8 |
|
|
|
61.2 |
|
|
Income tax provision, as adjusted |
|
75.2 |
|
|
|
85.7 |
|
|
Depreciation expense |
|
28.3 |
|
|
|
27.6 |
|
|
Amortization of non-acquisition related intangible assets |
|
2.3 |
|
|
|
2.3 |
|
|
Interest income on cash and cash equivalents |
|
(5.1 |
) |
|
|
(10.3 |
) |
|
Adjusted Net Income |
$ |
304.6 |
|
|
$ |
293.2 |
|
|
|
|
|
|
||||
|
Free Cash Flow: |
|
|
|
||||
|
Cash flows from operating activities |
$ |
199.7 |
|
|
$ |
256.4 |
|
|
Minus: |
|
|
|
||||
|
Capital expenditures |
|
36.3 |
|
|
|
33.7 |
|
|
Free Cash Flow |
$ |
163.4 |
|
|
$ |
222.7 |
|
|
RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET INCOME (Unaudited; in millions) |
|||||||
|
|
For the Three Month Period Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Orders |
|
|
|
||||
|
|
$ |
1,557.9 |
|
|
$ |
1,487.0 |
|
|
Precision and Science Technologies |
|
420.1 |
|
|
|
395.3 |
|
|
Total Orders |
$ |
1,978.0 |
|
|
$ |
1,882.3 |
|
|
Revenue |
|
|
|
||||
|
|
$ |
1,444.5 |
|
|
$ |
1,352.1 |
|
|
Precision and Science Technologies |
|
402.7 |
|
|
|
364.7 |
|
|
Total Revenue |
$ |
1,847.2 |
|
|
$ |
1,716.8 |
|
|
Segment Adjusted EBITDA |
|
|
|
||||
|
|
$ |
385.5 |
|
|
$ |
389.1 |
|
|
Precision and Science Technologies |
|
121.9 |
|
|
|
106.2 |
|
|
Total Segment Adjusted EBITDA |
$ |
507.4 |
|
|
$ |
495.3 |
|
|
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes: |
|
|
|
||||
|
Corporate expenses not allocated to segments |
$ |
38.3 |
|
|
$ |
35.6 |
|
|
Interest expense |
|
63.8 |
|
|
|
61.2 |
|
|
Depreciation and amortization expense |
|
135.8 |
|
|
|
118.9 |
|
|
Restructuring and related business transformation costs |
|
8.7 |
|
|
|
5.4 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
13.6 |
|
|
|
9.8 |
|
|
Stock-based compensation |
|
15.9 |
|
|
|
14.2 |
|
|
Foreign currency transaction losses, net |
|
2.2 |
|
|
|
6.8 |
|
|
Adjustments to LIFO inventories |
|
5.4 |
|
|
|
3.0 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
(0.2 |
) |
|
Interest income on cash and cash equivalents |
|
(5.1 |
) |
|
|
(10.3 |
) |
|
Other adjustments |
|
(1.1 |
) |
|
|
(2.2 |
) |
|
Income Before Income Taxes |
|
229.9 |
|
|
|
253.1 |
|
|
Provision for income taxes |
|
36.1 |
|
|
|
58.5 |
|
|
Loss on equity method investments |
|
— |
|
|
|
(6.2 |
) |
|
Net Income |
$ |
193.8 |
|
|
$ |
188.4 |
|
|
ORDERS AND REVENUE GROWTH (DECLINE) BY SEGMENT1 |
|||||
|
|
For the Three Month Period Ended |
||||
|
|
Orders |
|
Revenue |
||
|
|
|
|
|
||
|
Organic decline |
(1.9 |
%) |
|
(0.3 |
%) |
|
Impact of foreign currency |
4.0 |
% |
|
4.2 |
% |
|
Impact of acquisitions |
3.0 |
% |
|
3.7 |
% |
|
Total orders and revenue growth |
5.1 |
% |
|
7.6 |
% |
|
|
|
|
|
||
|
Industrial |
|
|
|
||
|
Organic decline |
(2.6 |
%) |
|
(1.6 |
%) |
|
Impact of foreign currency |
4.1 |
% |
|
4.2 |
% |
|
Impact of acquisitions |
3.3 |
% |
|
4.2 |
% |
|
Total orders and revenue growth |
4.8 |
% |
|
6.8 |
% |
|
|
|
|
|
||
|
Precision & Science Technologies |
|
|
|
||
|
Organic growth |
0.6 |
% |
|
4.4 |
% |
|
Impact of foreign currency |
3.9 |
% |
|
3.9 |
% |
|
Impact of acquisitions |
1.8 |
% |
|
2.1 |
% |
|
Total orders and revenue growth |
6.3 |
% |
|
10.4 |
% |
|
1 Organic growth/(decline), impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period. |
|||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260428838830/en/
Investor Relations:
Matthew.Fort@irco.com
Media:
Sara.Hassell@irco.com
Source: